Mutation analysis of ovarian carcinoma patients presenting optimal response to neoadjuvant chemotherapy

被引：0
|
作者：
Rouleau, Etienne [1 ]
dos Santos, Elizabeth Santana [2 ]
Maela, Francilette [1 ]
Lacroix, Ludovic [1 ]
Auguste, Aurelie [1 ]
Pautier, Patricia [1 ]
Morice, Philippe [1 ]
Genestie, Catherine [1 ]
Leary, Alexandra [1 ]
机构：
[1] Inst Gustave Rousy, Villejuif, France
[2] AC Camargo Canc Ctr, Sao Paulo, Brazil
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-3504
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3504
引用
收藏
页数：2
相关论文
共 50 条
  • [21] THE IMPACT OF CHEMOTHERAPY RESPONSE SCORE AND LYMPHOCYTIC INFILTRATION IN PATIENTS WITH OVARIAN CANCER TREATED WITH NEOADJUVANT CHEMOTHERAPY
    Rodolakis, I.
    Prodromidou, A.
    Sotiropoulou, M.
    Liontos, M.
    Haidopoulos, D.
    Bamias, A.
    Loutradis, D.
    Thomakos, N.
    Rodolakis, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A209 - A209
  • [22] Prognostic Value of Pathologic Chemotherapy Response Score in Patients With Ovarian Cancer After Neoadjuvant Chemotherapy
    Michaan, Nadav
    Chong, Woo Yoo
    Han, Na Young
    Lim, Myong Cheol
    Park, Sang Yoon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (09) : 1676 - 1682
  • [23] The clinical response of advanced epithelial ovarian cancer patients to neoadjuvant chemotherapy in China
    Yao, K.
    Bian, C.
    Li, L.
    Wu, Y.
    Zhao, X.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (03) : 377 - 380
  • [24] Chemotherapy response score: Validation of a three-tier system to quantify histopathologic response to neoadjuvant chemotherapy in ovarian carcinoma.
    Kubalanza, Kari
    Kim, Teresa
    Zhang, Mingyan
    Cohen, Joshua Garrett
    Memarzadeh, Sanaz
    Zakhour, Mae
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] HISTOPATHOLOGICAL RESPONSE ON CLINICORADIOLOGICAL PRESENTATION AND PROGNOSIS OF PATIENTS WITH ADVANCED HIGH GRADE SEROUS OVARIAN CARCINOMA TREATED WITH NEOADJUVANT CHEMOTHERAPY
    Lopes, A.
    Genta, M. L. Nogueira D.
    da Costa Miranda, V.
    Mendonza Lopez, R. V.
    Marino Carvalho, F.
    Paula Carvalho, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A48 - A49
  • [26] External validation of a 'response score' after neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma with complete clinical response
    Zorzato, Pier Carlo
    Zannoni, Gian Franco
    Tudisco, Riccardo
    Pasciuto, Tina
    Di Giorgio, Andrea
    Franchi, Massimo
    Scambia, Giovanni
    Fagotti, Anna
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (01) : 67 - 73
  • [27] Measuring response to neoadjuvant chemotherapy in high-grade serous tubo-ovarian carcinoma: an analysis of the correlation between CT imaging and chemotherapy response score
    McNulty, Meabh
    Das, Adarsh
    Cohen, Paul A.
    Dean, Andrew
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (05) : 929 - 934
  • [28] What is the optimal strategy to confirm the diagnosis of epithelial ovarian carcinoma (EOC) prior to neoadjuvant chemotherapy (NAC)?
    Dodge, J. E.
    Mackay, H.
    Klachook, S.
    Bernardini, M.
    Shaw, P.
    Murphy, K. J.
    Lo, E.
    Rosen, B. P.
    Freedman, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] The prognostic significance of chemotherapy response score and lymphocytic infiltration in patients with ovarian cancer treated with neoadjuvant chemotherapy
    Rodolakis, J.
    Prodromidou, A.
    Thomakos, N.
    Sotiropoulou, M.
    Liontos, M.
    Haidopoulos, D.
    Rodolakis, A.
    Loutradis, D.
    Bamias, A.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2022, 270 : E34 - E34
  • [30] The prognostic value of chemotherapy response score and lymphocytic infiltration ovarian cancer patients treated with neoadjuvant chemotherapy
    Liontos, M.
    Sotiropoulou, M.
    Kaparelou, M.
    Tzannis, K.
    Tsironis, G.
    Kyriazoglou, A.
    Tsiara, A.
    Zakopoulou, R.
    Rodolakis, I.
    Koutsoukos, K.
    Zagouri, F.
    Thomakos, N.
    Haidopoulos, D.
    Rodolakis, A.
    Bamias, A.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 83 - 84
12345